Данная лекция предназначена для студентов медицинских вузов, ординаторов, урологов, неврологов, а также врачей-реабилитологов. Целью представленного материала является освящение вопросов этиологии, патогенеза, диагностики, лечения, а также методов профилактики инфекции мочевыводящих путей у пациентов с травмой спинного мозга, основываясь на исследованиях, выполненных в последние годы, а также результатах собственной работы. Итогом работы является формулировка основных этапов лечения, а также методов профилактики инфекции мочевых путей у пациентов с травмой спинного мозга.
This lecture is for medical students, residents, urologists, neurologists and rehabilitologist. The aim of the presented material is the explanation of the etiology, pathogenesis, diagnosis, treatment and prevention methods of urinary tract infection in patients with spinal cord injury based on data from studies carried out in recent years, and the results of our own work. The result of the lecture is a statement of the main stages of treatment, and methods of prevention of urinary tract infection in patients with spinal cord injury.
1. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113: 67S–79S.
2. Grabe M, Bartoletti R, Bjerklund TE et al. Guidelines on Urological Infections. European Association of Urology, 2015; р. 86.
3. Togan T, Azap OK, Durukan E et al. The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J Microbiol 2014;7: e8905.
4. Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol 2016; 5: 72–87.
5. Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn 2014; 33: 95–100.
6. Vaidyanathan S, McDicken IW, Soni BM et al. Secretory immunoglobulin A in the vesicaluro the liumofpatients with neuropathicbladder-an immunohistochemical study. Spinal Cord 2000; 38: 378–81.
7. Iversen PO, Hjeltnes N, Holm B et al. Depressed immunity and impairedproliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000; 96: 2081–3.
8. Spaulding CN, Hultgren SJ. Adhesive Pili in UTI Pathogenesis and Drug Development. Pathogens 2016; 5: 30.
9. Jacobsen SM, Stickler DJ, Mobley HL et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008; 21: 26–59.
10. Lange D, Chew B. The Role of Bacteria in Urology. London: Springer, 2016; р. 106.
11. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003; 17: 411–32.
12. Blok B, Pannek J, Castro Diaz D et al. Guidelines on Neuro-Urology. European Association of Urology, 2015; р. 52.
13. Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value ofurinary tract infection signs and symptoms in individuals with spinalcord injury on intermittent catheterization. J Spinal Cord Med 2009; 32: 568–73.
14. Ronco E, Denys P, Bernede-Bauduin C et al. Diagnostic Criteria of Urinary Tract Infection in Male Patients With Spinal Cord Injury. Neurorehabil Neural Repair 2011; 25: 351–8.
15. Cardenas DD, Hooton TM. Medical complications in physical medicine and rehabilitation. NY: Demos Medical Publishing, 2015; р. 309.
________________________________________________
1. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113: 67S–79S.
2. Grabe M, Bartoletti R, Bjerklund TE et al. Guidelines on Urological Infections. European Association of Urology, 2015; р. 86.
3. Togan T, Azap OK, Durukan E et al. The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J Microbiol 2014;7: e8905.
4. Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol 2016; 5: 72–87.
5. Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn 2014; 33: 95–100.
6. Vaidyanathan S, McDicken IW, Soni BM et al. Secretory immunoglobulin A in the vesicaluro the liumofpatients with neuropathicbladder-an immunohistochemical study. Spinal Cord 2000; 38: 378–81.
7. Iversen PO, Hjeltnes N, Holm B et al. Depressed immunity and impairedproliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000; 96: 2081–3.
8. Spaulding CN, Hultgren SJ. Adhesive Pili in UTI Pathogenesis and Drug Development. Pathogens 2016; 5: 30.
9. Jacobsen SM, Stickler DJ, Mobley HL et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008; 21: 26–59.
10. Lange D, Chew B. The Role of Bacteria in Urology. London: Springer, 2016; р. 106.
11. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003; 17: 411–32.
12. Blok B, Pannek J, Castro Diaz D et al. Guidelines on Neuro-Urology. European Association of Urology, 2015; р. 52.
13. Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value ofurinary tract infection signs and symptoms in individuals with spinalcord injury on intermittent catheterization. J Spinal Cord Med 2009; 32: 568–73.
14. Ronco E, Denys P, Bernede-Bauduin C et al. Diagnostic Criteria of Urinary Tract Infection in Male Patients With Spinal Cord Injury. Neurorehabil Neural Repair 2011; 25: 351–8.
15. Cardenas DD, Hooton TM. Medical complications in physical medicine and rehabilitation. NY: Demos Medical Publishing, 2015; р. 309.
Авторы
Р.В.Салюков*1,2, А.С.Колмаков3,4
1 ФГАОУ ВО «Российский университет дружбы народов». 117198, Россия, Москва, ул. Миклухо-Маклая, д. 6;
2 ОАО «Реабилитационный центр для инвалидов “Преодоление”». 127083, Россия, Москва, ул. 8-го Марта, д. 6а, стр. 1;
3 ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1;
4 ООО «Многопрофильный медицинский центр “ДеВита”». 117452, Россия, Москва, Симферопольский б-р, д. 24, корп. 4 *salyukov2012@yandex.ru
________________________________________________
R.V.Salyukov*1,2, A.S.Kolmakov3,4
1 People’s Friendship University of Russia. 117198, Russian Federation, Moscow, ul. Miklukho-Maklaya, d. 6;
2 “Overcoming” Rehabilitation Center for Persons With Disabilities. 127083, Russian Federation, Moscow, ul. 8-go Marta, d. 6a, str. 1;
3 N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1;
4 “Devita” Multidisciplinary Medical Center. 117452, Russian Federation, Moscow, Simferopol'skii b-r, d. 24, korp. 4
*salyukov2012@yandex.ru